Impaired 11β-hydroxysteroid dehydrogenase type 2 activity in kidney disease disrupts 11-oxygenated androgen biosynthesis.
Tomkins M, McDonnell T, Cussen L, Sagmeister MS, Oestlund I, Shaheen F, Harper L, Hardy RS, Taylor AE, Gilligan LC, Arlt W, McIlroy M, de Freitas D, Conlon P, Magee C, Denton M, O'Seaghdha C, Snoep JL, Storbeck KH, Sherlock M, O'Reilly MW.
Tomkins M, et al. Among authors: sherlock m.
J Clin Endocrinol Metab. 2024 Oct 9:dgae714. doi: 10.1210/clinem/dgae714. Online ahead of print.
J Clin Endocrinol Metab. 2024.
PMID: 39382395